Abeona Therapeutics adopts amended bylaws raising quorum to 50% and enhancing shareholder proposal rules

ABEONA THERAPEUTICS INC.

Stockholder meeting quorum increased from one-third to 50% of shares entitled to vote.
Meetings may be held virtually by remote communication; stockholder list examination requirement eliminated.
Enhanced disclosure and representation requirements for stockholder proposals and director nominations.
Clarified procedures for calling, postponing, rescheduling annual and special meetings.
Added procedural requirements for universal proxy rules compliance under Rule 14a-19.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ABEONA THERAPEUTICS INC.: Adoption of Third Amended and Restated Bylaws effective March 16, 2026, making multiple changes including quorum increase to 50%, virtual meeting authorization, and enhanced stockholder proposal and director nomination procedures (effective 2026-03-16).

Change: bylaw amendment
Effective: 2026-03-16

Exact text from the filing

On March 16, 2026, the Board of Directors (the “Board”) of Abeona Therapeutics Inc. (the “Company”) approved the adoption of the Third Amended and Restated Bylaws of the Company, effective as of March 16, 2026 (the “New Bylaws”), which amend and restate the Second Amended and Restated Bylaws of the Company, dated as of July 9, 2024 (the “Existing Bylaws”), in their entirety.

View on SEC.gov

41 governance changes filed in the last 30 days. Browse all governance changes →

ABEONA THERAPEUTICS INC. filing history →

Source: SEC EDGAR

accession 0001493152-26-011863

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.